Switzerland-based pesticides maker Syngenta said on Wednesday that it has acquired a repository of natural compounds and ...

Syngenta is continuing to grow its biologicals division with the recent acquisition of certain Novartis technologies.

Syngenta, a world leader in developing the next generation of biologicals products for agricultural use, is significantly ...

Syngenta, which has a major operational base in Greensboro, said Wednesday it has signed an agreement to acquire certain product rights from Novartis, along with the recent opening of its ...

Syngenta, a global leader in agricultural innovation, has announced significant expansions in its biologicals sector by acquiring key assets from Novartis and inaugurating a new production facility in ...

The transaction includes the Novartis repository of natural compounds and genetic strains for agricultural use.

Syngenta has acquired Novartis’ natural products and genetic strains assets to enhance its biologicals research capabilities and support the agri ...

Controversial agrochemicals giant Syngenta has extensive academic, research and professional ties to the University of York, a Nouse investigation can reveal. Pesticides produced and exported by ...

"We're still very cautious," says Heinz Imhof, head of Novartis's agribusiness unit and chairman designate of the new combined company, to be called Syngenta AG. "Agricultural commodity prices haven't ...

Upon U.S. registration, isocycloseram, the AI found in Opello and Equento insecticides, will provide early-season insect ...

Novartis has finally given up on iscalimab after deciding that the anti-CD40 antibody is not worth pursuing in Sjögren’s syndrome. On a fourth-quarter earnings call with the media this morning ...

After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. At Novartis, CEO Vas Narasimhan’s overall 2024 pay ...